)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Guangzhou Baiyunshan Pharmaceutical Holdings Company (874) investor relations material
Guangzhou Baiyunshan Pharmaceutical Holdings Company Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary15 Aug, 2025
Executive summary
Operating revenue for H1 2025 reached RMB41.83 billion, up 1.93% year-over-year, while net profit attributable to shareholders declined 1.31% to RMB2.52 billion due to weaker performance in certain segments and increased competition.
The company maintained a strong industry position with a diversified portfolio in TCM, pharmaceuticals, health products, and distribution, and continued to expand its international footprint and digital transformation initiatives.
Digital transformation, innovation, and internationalization were prioritized, with new product launches, overseas registrations, and strategic partnerships expanding the global footprint.
An interim cash dividend of RMB0.40 per share (totaling RMB650.3 million) was approved, to be paid before the end of September 2025.
Financial highlights
Operating revenue: RMB41.83 billion (+1.93% YoY); net profit attributable to shareholders: RMB2.52 billion (-1.31% YoY); total profit: RMB3.09 billion (-4.30% YoY).
Net cash flow from operating activities: -RMB3.40 billion, a significant decrease due to lower receivables collection and higher procurement payments.
Basic EPS: RMB1.548 (-1.31% YoY); net assets per share: RMB23.23 (+5.17% from end-2024).
Gross margin for principal operations: 18.19% (down 0.7 percentage points YoY).
Segment revenue: Great Southern TCM RMB5.24 billion (-15.23% YoY), Great Health RMB7.02 billion (+7.42% YoY), Great Commerce RMB29.0 billion (+4.25% YoY).
Outlook and guidance
The company will focus on endogenous growth and external expansion, strengthen product development, accelerate internationalization, and continue digital transformation in H2 2025.
Capital expenditure for 2025 is expected to be RMB2.02 billion, with RMB0.65 billion spent in H1.
No plans for new fundraising in the next year; future fundraising will be assessed based on market and strategic needs.
Continued internationalization, targeting Southeast Asia, Middle East, North America, and Europe, with emphasis on TCM product registration and local brand building.
Ongoing digital transformation and innovation to enhance productivity and smart manufacturing.
Assess impact of regulatory policies on profit.
Elaborate on international market expansion plans.
Detail capital expenditure allocation for 2025.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q3 202528 Oct, 2025
Next Guangzhou Baiyunshan Pharmaceutical Holdings Company earnings date
Q3 202528 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage